These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22893397)

  • 21. Prophylactic fenbendazole therapy does not affect the incidence and onset of type 1 diabetes in non-obese diabetic mice.
    Franke DD; Shirwan H
    Int Immunol; 2006 Mar; 18(3):453-8. PubMed ID: 16415097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to prevention and treatment of IDDM in animal models.
    Gottlieb PA; Rossini AA; Mordes JP
    Diabetes Care; 1988; 11 Suppl 1():29-36. PubMed ID: 3069388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
    Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
    Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
    Tracy S; Drescher KM
    Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The NOD mouse as a model of type I diabetes.
    Tochino Y
    Crit Rev Immunol; 1987; 8(1):49-81. PubMed ID: 2961513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 12 and autoimmune diabetes.
    Adorini L
    Nat Genet; 2001 Feb; 27(2):131-2. PubMed ID: 11175771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Puzzling diabetic transgenic mice: a lesson for human type 1 diabetes?
    Pujol-Borrell R; Bottazzo GF
    Immunol Today; 1988 Oct; 9(10):303-6. PubMed ID: 3076399
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of interferon alpha in initiation of type I diabetes in the NOD mouse.
    Li Q; McDevitt HO
    Clin Immunol; 2011 Jul; 140(1):3-7. PubMed ID: 21592863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
    Cannons JL; Chamberlain G; Howson J; Smink LJ; Todd JA; Peterson LB; Wicker LS; Watts TH
    J Autoimmun; 2005 Aug; 25(1):13-20. PubMed ID: 15998581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental autoimmune diabetes: a new tool to study mechanisms and consequences of insulin-specific autoimmunity.
    Rajasalu T; Barth C; Spyrantis A; Durinovic-Belló I; Uibo R; Schirmbeck R; Boehm BO; Karges W
    Ann N Y Acad Sci; 2004 Dec; 1037():208-15. PubMed ID: 15699519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Animal models of type 1 diabetes: genetics and immunological function.
    Lang J; Bellgrau D
    Adv Exp Med Biol; 2004; 552():91-116. PubMed ID: 15622960
    [No Abstract]   [Full Text] [Related]  

  • 35. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.
    Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM
    J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.
    Driver JP; Serreze DV; Chen YG
    Semin Immunopathol; 2011 Jan; 33(1):67-87. PubMed ID: 20424843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.
    Fiorina P; Jurewicz M; Augello A; Vergani A; Dada S; La Rosa S; Selig M; Godwin J; Law K; Placidi C; Smith RN; Capella C; Rodig S; Adra CN; Atkinson M; Sayegh MH; Abdi R
    J Immunol; 2009 Jul; 183(2):993-1004. PubMed ID: 19561093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Funda DP; Palová-Jelínková L; Goliáš J; Kroulíková Z; Fajstová A; Hudcovic T; Špíšek R
    Front Immunol; 2019; 10():967. PubMed ID: 31139178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.
    Driver JP; Chen YG; Mathews CE
    Rev Diabet Stud; 2012; 9(4):169-87. PubMed ID: 23804259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of nonobese diabetic mice to understand human type 1 diabetes.
    Thayer TC; Wilson SB; Mathews CE
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):541-61. PubMed ID: 20723819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.